Biologics in Singapore are registered through the Health Sciences Authority (HSA). The process involves submitting a New Drug Application (NDA) with comprehensive data on quality, safety, and efficacy. Evaluation includes scientific assessment and Good Manufacturing Practice (GMP) compliance. Successful applications receive marketing authorization, allowing distribution within Singapore.